- Home
- CELU vs OKUR Comparison
CELU vs OKUR Comparison
Compare CELU & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- OKUR
- Stock Information
- Founded
- CELU 2016
- OKUR 2011
- Country
- CELU United States
- OKUR United States
- Employees
- CELU N/A
- OKUR N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- OKUR
- Sector
- CELU Health Care
- OKUR
- Exchange
- CELU Nasdaq
- OKUR NYSE
- Market Cap
- CELU 42.2M
- OKUR 34.9M
- IPO Year
- CELU N/A
- OKUR N/A
- Fundamental
- Price
- CELU $3.03
- OKUR $2.36
- Analyst Decision
- CELU
- OKUR Strong Buy
- Analyst Count
- CELU 0
- OKUR 4
- Target Price
- CELU N/A
- OKUR $32.25
- AVG Volume (30 Days)
- CELU 491.2K
- OKUR 69.3K
- Earning Date
- CELU 05-08-2025
- OKUR 08-14-2025
- Dividend Yield
- CELU N/A
- OKUR N/A
- EPS Growth
- CELU N/A
- OKUR N/A
- EPS
- CELU N/A
- OKUR N/A
- Revenue
- CELU $54,220,000.00
- OKUR N/A
- Revenue This Year
- CELU $23.29
- OKUR N/A
- Revenue Next Year
- CELU N/A
- OKUR N/A
- P/E Ratio
- CELU N/A
- OKUR N/A
- Revenue Growth
- CELU 138.11
- OKUR N/A
- 52 Week Low
- CELU $1.00
- OKUR $1.70
- 52 Week High
- CELU $5.22
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- CELU 71.05
- OKUR N/A
- Support Level
- CELU $2.01
- OKUR N/A
- Resistance Level
- CELU $2.66
- OKUR N/A
- Average True Range (ATR)
- CELU 0.24
- OKUR 0.00
- MACD
- CELU 0.08
- OKUR 0.00
- Stochastic Oscillator
- CELU 91.67
- OKUR 0.00
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.